|
Volumn 96, Issue 2, 2001, Pages 203-210
|
Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine
|
Author keywords
Branched DNA; Hepatitis B virus; Lamivudine
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS E ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ARTICLE;
ASSAY;
CONTROLLED STUDY;
DRUG EXPOSURE;
GENOTYPE;
HEPATITIS B;
HUMAN;
LUMINESCENCE;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RELIABILITY;
REPRODUCIBILITY;
BRANCHED DNA SIGNAL AMPLIFICATION ASSAY;
DNA, VIRAL;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
LAMIVUDINE;
REPRODUCIBILITY OF RESULTS;
REVERSE TRANSCRIPTASE INHIBITORS;
SENSITIVITY AND SPECIFICITY;
CHIRON;
HEPATITIS B VIRUS;
|
EID: 0034969118
PISSN: 01660934
EISSN: None
Source Type: Journal
DOI: 10.1016/S0166-0934(01)00335-4 Document Type: Article |
Times cited : (2)
|
References (10)
|